Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
BMC Neurol
.
2023 Sep 6;23(1):318.
doi: 10.1186/s12883-023-03368-3.
Authors
Jessica Ailani
1
,
Peter McAllister
2
,
Paul K Winner
3
,
George Chakhava
4
,
Mette Krog Josiassen
5
,
Annika Lindsten
5
,
Bjørn Sperling
5
,
Anders Ettrup
5
,
Roger Cady
6
7
Affiliations
1
Department of Neurology, Georgetown University Hospital, Washington, DC, USA.
2
New England Institute for Neurology and Headache, Stamford, CT, USA.
3
Palm Beach Headache Center, West Palm Beach, FL, USA.
4
Georgian Association of Medical Specialties, Multiprofile Clinic Consilium Medulla, D.Tvildiani Medical University, Tbilisi, Georgia.
5
H. Lundbeck A/S, Copenhagen, Denmark.
6
Lundbeck LLC, Deerfield, IL, USA.
[email protected]
.
7
RK Consults, Ozark, MO, USA.
[email protected]
.
PMID:
37674117
PMCID:
PMC10481482
DOI:
10.1186/s12883-023-03368-3
No abstract available
Publication types
Published Erratum